Instruments

Name Stock exchange Average volume Price Type
UMA EXPORTS LIMITED UMAEXPORTS

NSE India S.E. +1 Other

10,153 93.8 INR Stock Uma Exports Limited Stock
UMA EXPORTS LIMITED UMAEXPORTS

Bombay S.E.

1,291 93.2 INR Stock Uma Exports Limited
UMA CONVERTER LIMITED UMA

NSE India S.E.

41,231 29.4 INR Stock Uma Converter Limited Stock
UMA EXPORTS LTD. UMAEXPORTS

NSE India S.E.

10,714 94.85 INR Stock Uma Exports Ltd. Stock
SBL UMA 10./MAY27/

Bombay S.E.

- - % Bond SBL UMA 10./MAY27/ Bond

News (63)

APTE BIOS : 2023 ESH Poster – Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy as Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) PU
BridgeBio Pharma : BBIO – Acoramidis AG10 TTR – HFSA 2023 – 4 Year Update from OLE Phase 2 Study PU
Transcript : Balaji Amines Limited, Q1 2024 Earnings Call, Sep 08, 2023
Transcript : BridgeBio Pharma, Inc. - Special Call
Gabriel India : Interim Dividend –FY 16 PU
Gabriel India : Interim Dividend –FY 17 PU
Disc Medicine : Corporate Presentation PU
Transcript : ProKidney Corp. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 03:45 PM
BridgeBio Pharma : BBIO - JPM 2023 presentation PU
Sangam India : SANGAM_INDIA_UNPAID DIV2022_FORM IEPF-2 PU
BridgeBio Pharma Presents 12-month Results from Phase 2 Study of BBP-418 in Limb-Girdle Muscular Dystrophy Type 2i AQ
BridgeBio Pharma Presents 12-month Results from Phase 2 Study of BBP-418 in Limb-Girdle Muscular Dystrophy Type 2i (LGMD2i) GL
BridgeBio Pharma Presents 12-month Results from Phase 2 Study of BBP-418 in Limb-Girdle Muscular Dystrophy Type 2i (LGMD2i) AQ
BridgeBio Pharm and ML Bio Solutions Present 12-month Results from Phase 2 Study of BBP-418 in Limb-Girdle Muscular Dystrophy Type 2i CI
Vedanta : Newspaper Advertisements PU
BridgeBio Pharma Announces Dosing of First Patient in Phase 1 Trial of BBP-671, a Potential Best-In-Class Treatment for Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA) GL
ProKidney : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q) PU
Gabriel India : Final Dividend-FY15 PU
PROKIDNEY CORP. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Registrant's Certifying Accountant, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Other Events, Financial Statements and Exhibits (form 8-K) AQ
SOCL CAPI : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K PU
Social Capital Suvretta III : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K PU
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III AQ
Shri Piyush Goyal exhorts the designers to work in synergy to ensure that identified craft people earns Rs.1000/- more every month PU
India Glycols : Statement of Unpaid & Unclaimed Dividend for FY 2020-21 PU
India Glycols : List of shareholders' unpaid unclaimed dividend amount as on 31st March 2021 PU
India Glycols : List of shareholders' unpaid/unclaimed dividend amount as on 31st March 2021 PU
Gabriel India : Unpaid Dividend – FY20 PU
BridgeBio Pharma : R&D Day 2021 PU
Transcript : BridgeBio Pharma, Inc. - Special Call
BridgeBio Pharma : Announces Progress in its KRAS Portfolio, New Gene Therapy Programs, and Updates on Advancements Across its R&D Pipeline Targeting Genetic Diseases and Cancers PU
BridgeBio : Pharma to Host Virtual R&D Day on October 12, 2021 PR
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) AQ
Social Capital Suvretta Holdings Corp. III Announces Board Changes CI
NTPC : 33rd Unpaid Interim Dividend 2020-21..... Click here to view/download PU
Transcript : BridgeBio Pharma, Inc. - Special Call
EIDOS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles (form 8-K) AQ
Eidos Therapeutics, Inc. Announces Board Changes CI
BridgeBio Pharma : Corporate Presentation August 2020 PU
BridgeBio Pharma : ML Bio Solutions Announces Dosing Of First Subject In Phase 1 Clinical Trial Of BBP-418 For Limb Girdle Muscular Dystrophy Type 2i (LGMD2i) AQ
BridgeBio Pharma’s ML Bio Solutions Announces Dosing of First Subject in Phase 1 Clinical Trial of BBP-418 For Limb Girdle Muscular Dystrophy Type 2i (LGMD2i) GL
Transcript : BridgeBio Pharma, Inc. - Shareholder/Analyst Call
EIDOS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K) AQ
Transcript : Eidos Therapeutics, Inc. - Shareholder/Analyst Call
BridgeBio Pharma : Corporate Presentation March 2020 PU
Transcript : BridgeBio Pharma, Inc. Presents at Cowen and Company 40th Annual Health Care Conference, Mar-04-2020 09:20 AM
12NextSee all

Companies (6)

MAG HOLDINGS 66 M $
Logo MAG Holdings

MAG Holdings Berhad is a Malaysia-based investment holding company. The Company and its subsidiaries are principally engaged in the live prawn aquaculture business. The Company operates through business of prawn aquaculture and seafood processing segment. ...

TENNANT COMPANY 1 994 M $
Logo Tennant Company

Tennant Company is engaged in designing, manufacturing and marketing solutions. The Company’s products include floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equip ...

PRAEMIUM LIMITED 146 M $
Logo Praemium Limited

Praemium Limited is a provider of portfolio administration, investment platforms and financial planning tools to the wealth management industry. The Company is engaged in the provision of virtual managed accounts and financial planning software licenses a ...

UMA CONVERTER LIMITED 7 M $
Logo Uma Converter Limited

UMA Converter Limited is an India-based manufacturer and exporter of flexible packaging material. The Company offers laminated film products. Its product categories include pouch form, roll form and coextruded films. The Company's pouch form products incl ...

UMA EXPORTS LIMITED 38 M $
Logo Uma Exports Limited

Uma Exports Limited is an India-based company, which is engaged in the trading and marketing of agricultural produce and commodities, such as sugar, spices like dry red chilies, turmeric, coriander, cumin seeds, food grains like rice, wheat, corn, sorghum ...

VICTORY CAPITAL HOLDINGS, INC. 3 345 M $
Logo Victory Capital Holdings, Inc.

Victory Capital Holdings, Inc. is a diversified global asset management firm. The Company provides specialized investment strategies to institutions, intermediaries, retirement platforms and individual investors. With 11 autonomous investment franchises a ...


Insiders

Picture Uma Sinha
Uma Sinha

Currently, Uma Sinha occupies the position of Chief Scientific Officer of BridgeBio Pharma, Inc. and Chief Scientific Officer for Eidos Therapeutics, Inc. (a subsidiary of BridgeBio Pharma, Inc.). Dr. Sinha previously held the position of Chief Scientific Officer of Global Blood Therapeutics, Inc., Principal at COR Therapeutics, Inc., Senior Director-Cardiovascular at Millennium Pharmaceuticals, Inc., Principal at Genencor International, Inc. and Vice President & Head-Biology at Portola Pharmaceuticals, Inc. She received a doctorate from the University of Georgia and an undergraduate degree from Presidency College.


Picture Sinha Uma
Sinha Uma

Sinha Uma has a current job as an Advisory Partner at Sand Hill East LLC since 2018.


Picture Uma
Uma

Uma currently works at Quality Foils (India) Ltd., as Independent Non-Executive Director from 2022 and R D Serenitea Pvt Ltd., as Director.
Ms. Uma received her graduate degree from Guru Jambheshwar University of Science & Technology and undergraduate degree from Deenbandhu Chhotu Ram University of Science & Technology.



Picture Uma Srinivasan Iyer
Uma Srinivasan Iyer

Uma Srinivasan Iyer is currently working as AGM-Corporate Communications & Digital Media at Soham Renewable Energy India Pvt Ltd.



Picture Uma Sreenivasan
Uma Sreenivasan

Uma Sreenivasan is currently the Vice President-Research & Development at Cerilliant Corp.
She started this position in 2013.
Prior to her current role, she obtained a doctorate degree from the University of Minnesota and an undergraduate degree from the University of Mumbai.




Picture Uma Bhargava
Uma Bhargava

Uma Bhargava is currently the Vice President-Finance at Loadstar Sensors, Inc. Previously, she worked as a Principal at General Electric Co. and as a Research Analyst at Salomon Smith Barney, Inc. She holds an MBA from Drexel University and both undergraduate and graduate degrees from the University of Rajasthan.

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW